Statistical power in clinical trials for Alzheimer's disease

 
   Lead Investigator:    David Moreno-Dominguez
   Institution      :    QMENTA
   E-Mail           :    david@qmenta.com
   Proposal ID      :    1082



   Proposal Description:
   The aim of this project is to estimate sample sizes for drug effect discrimination for clinical trials in Alzheimer's disease. We aim to develop consensus recommendations for minimal cohort sizes for clinical trials testing therapies for Alzheimer's disease by estimating the minimal sample sizes to be able to accurately discriminate between patients and controls, or disease sub-groups.